CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...

Cancer genomics is the study of the totality of DNA sequence and gene expression differences between tumour cells and normal host cells. It aims to understand the genetic basis of tumour cell ...

Hologic has signed a definitive agreement to acquire Reveal Genomics, a Barcelona-based precision oncology company developing ...

A new few-shot learning framework called scCAPReSE detects large-scale genomic rearrangements in single-cell Hi-C data using ...

Can a Cancer Genome Preserve Evidence of the Environmental Exposure That Helped Shape It? / Adam Butler, Anastassia Spiridou, ...

Genome sequencing traced a rare cancer’s spread between identical twins in the womb, revealing how tumors and blood cells ...

Hologic has agreed to acquire Reveal Genomics, adding the HER2DX assay to its breast cancer genomic testing portfolio, the ...

A prospective trial found constitutional pathogenic variants in about 10 percent of solid tumor patients screened through ...

Mark Burkard, MD, PhD, discussed genomic gaps, extreme survivors of metastatic breast cancer, and how minimal residual ...

For rural Mainers with cancer, advanced care once meant driving to Boston or traveling to an academic center. A decade in, the Jackson Laboratory’s Maine Cancer Genomics Initiative says it has flipped ...

The initiative represents the first time 10x Genomics widened its scope past solid tumours to include haematologic malignancies.